Topics

Therapeutic Utility of Germline Variants Is an "Open Question"

12:00 EDT 5 Jul 2019 | OncLive

Although heritable mutations have been implicated in cancer risk, the role that these abberations play in the development of malignancies with acquired mutations is a question that will require studies of large data sets of patients.

Original Article: Therapeutic Utility of Germline Variants Is an "Open Question"

NEXT ARTICLE

More From BioPortfolio on "Therapeutic Utility of Germline Variants Is an "Open Question""

Quick Search

Relevant Topic

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...